LGALS16 (galectin-16) is a β-galactoside-binding protein with primary functions in lactose binding and T-cell regulation. The gene encodes a soluble lectin that binds lactose with high affinity and acts as a strong inducer of T-cell apoptosis 1. LGALS16 is notably expressed in placental tissues, where its expression is regulated through cAMP-dependent signaling pathways. Mechanistically, LGALS16 expression is mediated by p38 MAPK and EPAC signaling branches rather than PKA, and the gene is upregulated during trophoblast differentiation in response to cAMP stimulation 2. LGALS16 is required for proper trophoblast-like differentiation, as evidenced by reduced chorionic gonadotropin expression in LGALS16 knockout cells 2. The gene is co-upregulated with syncytiotrophoblast-specific markers during hESC differentiation into trophoblast-like cells 3. Disease relevance includes altered expression patterns associated with cancer, diabetes, and brain diseases 1. Clinically, LGALS16's role in placental differentiation and immunoregulation suggests potential relevance to pregnancy complications and immune-related pathologies, though specific clinical applications remain underdeveloped due to limited functional characterization of this galectin family member.